Skip to content
  • Wednesday, 28 October 2026
  • 12:00 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Overcoming Cellular Differentiation Blocks
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Overcoming Cellular Differentiation Blocks

Dwi Wanna Jul 11, 2026 0

In a landmark advancement for hematologic oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy targeting acute…

Read More
Advanced Materials Science

RIKEN Physicists Pioneer Robust Nonreciprocal Quantum Synchronization for Phonons Overcoming Environmental Noise and Manufacturing Imperfections

Nila Kartika Wati Jul 7, 2026 0

A research team led by theoretical physicists at the RIKEN Center for Quantum Computing (RQC) has unveiled a groundbreaking theoretical…

Read More
Stem Cell & Regenerative Medicine

Novel Combination Therapy Offers Breakthrough Strategy for Overcoming Differentiation Blockade in Acute Myelogenous Leukemia

Dwi Wanna May 25, 2026 0

Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by its rapid progression and…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Unveils Dual-Inhibitor Strategy to Combat Acute Myelogenous Leukemia by Overcoming Cellular Differentiation Blockade

Dwi Wanna Mar 27, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…

Read More
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline ExpansionChemical Propulsion of Hemozoin Crystal Motion in Malaria ParasitesMicroplastics Linked to Neurodegenerative Diseases Through Multiple Biological Pathways According to New International StudyAstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ